Pre-earnings options volume in VistaGen Therapeutics is 2.6x normal with calls leading puts 8:7. Implied volatility suggests the market is anticipating a move near 19.2%, or $1.49, after results are released. Median move over the past eight quarters is 4.9%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VTGN:
